PDF VersionAutomated encrypted email sends secure patient results worldwide in real-time
DALLAS--(BUSINESS WIRE)--Nov. 30, 2011-- Zix Corporation (ZixCorp), (NASDAQ: ZIXI), the leader in email encryption services, was selected by ICON Central Laboratories to provide lab reports through an encrypted email solution for select sites participating in clinical trials. ICON Central Laboratories, a division of ICON plc, is a global central laboratory exclusively engaged in clinical trial testing. With laboratories located in New York, Dublin, Singapore, India and China, ICON Central Laboratories has tested and reported lab results for clinical trial subjects in more than 40,000 sites worldwide.
ICON Central Laboratories tracks patient results using ICOLIMS, a state-of-the-art laboratory information management system. Once recorded, ICOLIMS automatically sends patient results through ZixEnableSM, an application-generated email encryption service. With ZixEnable, patient results are delivered securely 24/7 worldwide, enabling physicians to better monitor and adjust patient treatment during clinical trials.
“The use of ICOLIMS in conjunction with ZixEnable provides more efficient results to physicians, increases patient safety and enhances the research environment for our sponsors,” said John Reinert, Vice President of Information Technology and Global Data Services for ICON Central Laboratories. “With encrypted email through ZixCorp, we can confidently send results to our global clinical sites around the clock through our automated processes. We also benefit from knowing the right clinical teams are accessing the appropriate data and that physicians can access the electronic information as much as needed.”
The pharmaceutical research industry has traditionally used fax machines to deliver patient results to clinical sites. The most significant challenges in faxing patient results are the inability to reach all clinical sites and the inability of physicians to manage the information electronically.
Physicians who use ZixGateway®, a policy-based email encryption appliance, receive patient results transparently in their inbox, requiring no extra steps or passwords to access the encrypted email. Physicians without ZixGateway receive encrypted email through ZixPort®, a secure Web portal. Regardless of delivery method, ICON Central Laboratories receives reports on who has received and opened the encrypted email.
“Application-generated encrypted email through ZixEnable is yet another example of the power of secure email and the innovation ZixCorp brings to the market,” said Rick Spurr, ZixCorp’s Chairman and Chief Executive Officer. “Automatic secure email is a strategic platform that many companies in the pharmaceutical, healthcare and financial industries can leverage to reach targeted audiences in real-time and meet regulatory requirements for secure data transmission. We appreciate ICON Central Laboratories’ trust in using our solution to send sensitive patient data.”
About ICON Central Laboratories
ICON Central Laboratories is dedicated exclusively to central laboratory testing and the associated services for clinical trials. Our global network of facilities in the US, Ireland, Singapore, India and China operate with identical analytical platforms, SOPs, QC materials and reagents to support large global studies. We offer an extensive test menu of safety, esoteric, and custom-developed assays plus specialized flow cytometry and expanded biomarker capabilities.
About Zix Corporation
Zix Corporation provides the only email encryption services designed with your most important relationships in mind. The most influential companies and government organizations use the proven ZixCorp® Email Encryption Services, including WellPoint, Humana, the SEC and more than 1,200 hospitals and 1,600 financial institutions. ZixCorp Email Encryption Services are powered by ZixDirectory®, the largest email encryption community in the world. The tens of millions of ZixDirectory members can feel secure knowing their most important relationships are protected. For more information, visit http://www.zixcorp.com.
Source: Zix Corporation
Taylor Stansbury Johnson, 214-370-2134